MALVESTITI, FRANCESCO
 Distribuzione geografica
Continente #
EU - Europa 2.689
AS - Asia 2.061
NA - Nord America 1.642
SA - Sud America 194
AF - Africa 60
OC - Oceania 33
Continente sconosciuto - Info sul continente non disponibili 3
Totale 6.682
Nazione #
US - Stati Uniti d'America 1.566
IT - Italia 1.489
CN - Cina 695
SG - Singapore 550
NL - Olanda 294
HK - Hong Kong 185
DE - Germania 171
RU - Federazione Russa 170
BR - Brasile 159
VN - Vietnam 150
BD - Bangladesh 120
SE - Svezia 104
GB - Regno Unito 91
IN - India 89
FR - Francia 80
FI - Finlandia 50
ID - Indonesia 46
JP - Giappone 45
IE - Irlanda 43
ES - Italia 39
CA - Canada 35
PL - Polonia 32
KR - Corea 31
TR - Turchia 31
AU - Australia 30
CH - Svizzera 30
MX - Messico 20
TW - Taiwan 20
CI - Costa d'Avorio 19
GR - Grecia 18
AT - Austria 17
IQ - Iraq 12
AR - Argentina 11
MY - Malesia 11
ZA - Sudafrica 10
EC - Ecuador 9
HU - Ungheria 9
PK - Pakistan 9
TH - Thailandia 9
PT - Portogallo 8
DK - Danimarca 7
SA - Arabia Saudita 7
UA - Ucraina 7
BE - Belgio 6
IR - Iran 6
AE - Emirati Arabi Uniti 5
CL - Cile 5
JM - Giamaica 5
RO - Romania 5
TN - Tunisia 5
CZ - Repubblica Ceca 4
EG - Egitto 4
LK - Sri Lanka 4
MA - Marocco 4
NG - Nigeria 4
NO - Norvegia 4
NP - Nepal 4
PH - Filippine 4
AZ - Azerbaigian 3
CO - Colombia 3
CR - Costa Rica 3
DZ - Algeria 3
HN - Honduras 3
JO - Giordania 3
KE - Kenya 3
LU - Lussemburgo 3
MO - Macao, regione amministrativa speciale della Cina 3
NZ - Nuova Zelanda 3
BO - Bolivia 2
EE - Estonia 2
GT - Guatemala 2
IL - Israele 2
KH - Cambogia 2
LB - Libano 2
PR - Porto Rico 2
PS - Palestinian Territory 2
SC - Seychelles 2
SI - Slovenia 2
UY - Uruguay 2
VE - Venezuela 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BG - Bulgaria 1
BM - Bermuda 1
CW - ???statistics.table.value.countryCode.CW??? 1
DM - Dominica 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GD - Grenada 1
GE - Georgia 1
GH - Ghana 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
MM - Myanmar 1
MN - Mongolia 1
MR - Mauritania 1
Totale 6.671
Città #
Singapore 306
Ashburn 231
Dallas 198
Council Bluffs 171
Milan 156
Hong Kong 152
San Jose 107
Hefei 93
Frankfurt am Main 69
Los Angeles 66
Beijing 63
New York 57
Ho Chi Minh City 51
Chandler 50
Rome 47
Dublin 41
Jakarta 36
Hanoi 33
Moscow 33
Bengaluru 32
Helsinki 31
Santa Clara 27
Guangzhou 26
Boardman 25
Buffalo 25
Lauterbourg 24
Nuremberg 24
Shanghai 24
Southend 22
São Paulo 21
The Dalles 21
Seoul 20
Abidjan 19
Chicago 19
Munich 18
Naples 18
Tokyo 18
Verona 18
Pontedera 17
Berlin 16
Columbus 16
Warsaw 16
Amsterdam 15
Istanbul 15
Thessaloniki 15
Turin 15
Hangzhou 14
Brooklyn 13
Houston 13
Atlanta 12
Cangzhou 12
Catania 12
Vienna 12
Zurich 12
Boston 11
Florence 11
Nanjing 10
Orem 10
Princeton 10
Toronto 10
Lappeenranta 9
London 9
Madrid 9
Melbourne 9
Palermo 9
Philadelphia 9
Sydney 9
Bologna 8
Fairfield 8
Haiphong 8
Seattle 8
Shenyang 8
Shenzhen 8
Tianjin 8
Bangkok 7
Bari 7
Oxford 7
Budapest 6
Changsha 6
City of London 6
Denver 6
Guadalajara 6
Osaka 6
Taipei 6
Barcelona 5
Bến Tre 5
Camerano 5
Central 5
Changchun 5
Chengdu 5
Coimbatore 5
Des Moines 5
Fuzhou 5
Guayaquil 5
Louisville 5
Magdeburg 5
Manchester 5
Nashville 5
Piscataway 5
Portland 5
Totale 2.941
Nome #
A second update on mapping the human genetic architecture of COVID-19 1.477
Mapping the human genetic architecture of COVID-19 1.115
Detailed stratified GWAS analysis for severe COVID-19 in four European populations 402
Adverse effect of PNPLA3 p.I148M genetic variant on kidney function in middle-aged individuals with metabolic dysfunction 342
Genetic insight into Covid-19 related liver injury 244
Rare ATG7 genetic variants predispose patients to severe fatty liver disease 196
Definition of Healthy Ranges for Alanine Aminotransferase Levels: A 2021 Update 188
Corrigendum to "SIRT5 rs12216101 T>G variant is associated with liver damage and mitochondrial dysfunction in patients with non-alcoholic fatty liver disease" [J Hepatol 80 (2024) 10-19] 172
Genetic predisposition similarities between NASH and ASH: Identification of new therapeutic targets 169
Exome-Wide Association Study on Alanine Aminotransferase Identifies Sequence Variants in the GPAM and APOE Associated With Fatty Liver Disease 167
Genome-wide association study of long COVID 166
Chromosome 3 cluster rs11385942 variant links complement activation with severe COVID-19 165
Circulating Interlukin-32 and Altered Blood Pressure Control in Individuals with Metabolic Dysfunction 164
Clinical and genetic determinants of the fatty liver–coagulation balance interplay in individuals with metabolic dysfunction 163
Impact of clonal hematopoiesis of indeterminate potential on hepatocellular carcinoma in individuals with steatotic liver disease 153
Alpha1-Antitrypsin Inherited Variants in Patients With Bronchiectasis 145
Programmed cell death 1 genetic variant and liver damage in nonalcoholic fatty liver disease 141
Predictors of controlled attenuation parameter in metabolic dysfunction 139
SIRT5 rs12216101 T>G variant is associated with liver damage and mitochondrial dysfunction in patients with non-alcoholic fatty liver disease 128
Liver Involvement in Patients with Rare MBOAT7 Variants and Intellectual Disability: A Case Report and Literature Review 123
Trends and risk factors of SARS-CoV-2 infection in asymptomatic blood donors 121
Diagnostic Uptake of Targeted Sequencing in Adults With Steatotic Liver Disease and a Suspected Genetic Contribution 114
IL32 downregulation lowers triglycerides and type I collagen in di-lineage human primary liver organoids 110
Validation of a targeted gene panel sequencing for the diagnosis of hereditary chronic liver diseases 107
Clinical exome sequencing for diagnosing severe cryptogenic liver disease in adults: A case series 105
Partitioned polygenic risk scores identify distinct types of metabolic dysfunction-associated steatotic liver disease 82
GENOME-WIDE ASSOCIATION STUDY OF NON-INVASIVE ASSESSMENT OF LIVER FIBROSIS IN MASLD: EVIDENCE FROM AN ITALIAN POPULATION 59
Carriage of rare APOB variants predisposes to severe steatotic liver disease and hepatocellular carcinoma 53
Genome-wide interaction study with body mass index identifies CYP7A1 and GIPR as genetic modulators of metabolic dysfunction-associated steatotic liver disease 50
IFNAR2 p.F8S Variant Associates with Severe COVID-19 and Adaptive Immune Cell Activation Modulation 46
Germline Variants Influence Chronic Liver Disease Progression through Distinct Pathways 27
Downregulation of interleukin 32 reduce intracellular triglyceride levels in liver spheroids 17
null 1
Totale 6.851
Categoria #
all - tutte 16.705
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.705


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202111 0 0 0 0 0 0 0 0 0 0 3 8
2021/2022256 9 15 18 9 12 18 26 24 39 22 32 32
2022/2023441 26 39 35 34 67 51 40 28 39 13 29 40
2023/2024709 53 54 49 90 140 47 87 39 31 22 53 44
2024/20251.817 46 131 85 146 117 106 156 175 167 174 212 302
2025/20263.594 298 330 416 294 302 232 368 302 354 271 427 0
Totale 6.851